901 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 901 shares of the company's stock, valued at approximately $270,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Congress Wealth Management LLC DE grew its holdings in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares in the last quarter. Evergreen Private Wealth LLC increased its holdings in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after purchasing an additional 35 shares during the period. Mediolanum International Funds Ltd boosted its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after purchasing an additional 36 shares during the period. Prairie Wealth Advisors Inc. increased its stake in HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after buying an additional 40 shares during the period. Finally, Whittier Trust Co. grew its holdings in shares of HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after acquiring an additional 41 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. KeyCorp lowered their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 17th. Bank of America dropped their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Royal Bank of Canada decreased their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $385.67.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded down $16.61 during mid-day trading on Friday, hitting $332.53. The company had a trading volume of 2,518,277 shares, compared to its average volume of 1,361,334. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market cap of $81.87 billion, a P/E ratio of 15.14, a PEG ratio of 1.10 and a beta of 1.68. The business's 50-day simple moving average is $327.23 and its 200-day simple moving average is $339.87.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.